- 专利标题: METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
-
申请号: EP16862624.0申请日: 2016-07-26
-
公开(公告)号: EP3371301A1公开(公告)日: 2018-09-12
- 发明人: VALAMEHR, Bahram , CLARKE, Raedun , BJORDAHL, Ryan
- 申请人: Fate Therapeutics, Inc.
- 申请人地址: Suite 200, 3535 General Atomics Court San Diego, California 92121 US
- 专利权人: Fate Therapeutics, Inc.
- 当前专利权人: Fate Therapeutics, Inc.
- 当前专利权人地址: Suite 200, 3535 General Atomics Court San Diego, California 92121 US
- 代理机构: Potter Clarkson LLP
- 优先权: US201562251016P 20151104; PCT/US2016/014918 20160126; US201662337093P 20160516
- 国际公布: WO2017078807 20170511
- 主分类号: C12N5/0789
- IPC分类号: C12N5/0789 ; A61K35/28 ; G01N33/569
摘要:
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells. The invention further provides pluripotent stem cell-derived hematopoietic cells generated using the culture platforms and methods disclosed herein, which enable feed-free, monolayer culturing and in the absence of EB formation. Specifically, pluripotent stem cell-derived hematopoietic cell of this invention include, and not limited to, iHSC, definitive hemogenic endothelium, hematopoietic multipotent progenitors, T cell progenitors, NK cell progenitors, T cells, NK cells, NKT cells and B cells.
信息查询